Veracyte
VCYT
$19.31
Share price
-0.87%
Change (1 day)
-13.37%
Change (1 year)
Categories
Veracyte (VCYT) - Total assets
Total assets on the balance sheet as of December 2023 : $1.11 B
According to Veracyte's latest financial reports the company's total assets are $1.11 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Veracyte - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.11 B | -3.59% |
| 2022-12-31 | $1.15 B | -2.64% |
| 2021-12-31 | $1.18 B | 159.83% |
| 2020-12-31 | $0.45 B | 66.11% |
| 2019-12-31 | $0.27 B | 128.13% |
| 2018-12-31 | $0.12 B | 53.35% |
| 2017-12-31 | $78.66 M | -22.14% |
| 2016-12-31 | $0.10 B | 34.27% |
| 2015-12-31 | $75.24 M | 16.05% |
| 2014-12-31 | $64.83 M | -18.57% |
| 2013-12-31 | $79.63 M | 317.63% |
| 2012-12-31 | $19.06 M | 82.44% |
| 2011-12-31 | $10.45 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $6.47 B | 480.44% | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.14 B | 2.83% | 🇺🇸 USA |
 Biocept
BIOC | $22.1 M | -98.02% | 🇺🇸 USA |